Research
Hormonal
Key gut hormones such as GLP-1, OXM, and PYY play a role in ameliorating Type 2 diabetes mellitus.
Therapies targeting GLP-1, OXM, and PYY may be beneficial for managing DM2.
StrongSupportsmedium confidence
One of the principal mechanisms by which bariatric surgery is capable of ameliorating DM2 is by means of increasing the secretion of key gut hormones such as glucagon-like peptide-1 (GLP-1), oxyntomodulin (OXM) and peptide YY (PYY).
Why this rating
The claim is based on a review of hormonal roles in the context of DM2 treatment.
Source
Gut hormones and Type 2 diabetes mellitus
Agnieszka Falinska et al. · Diabetes Management · 2014
DOI 10.2217/dmt.14.47
reviewCited 4×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →